File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.jhep.2019.05.014
- Scopus: eid_2-s2.0-85068818799
- PMID: 31668671
- WOS: WOS:000496939900041
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Nivolumab in Advanced Hepatocellular Carcinoma: Sorafenib-Experienced Asian Cohort Analysis From the CheckMate 040 Study
| Title | Nivolumab in Advanced Hepatocellular Carcinoma: Sorafenib-Experienced Asian Cohort Analysis From the CheckMate 040 Study |
|---|---|
| Authors | |
| Keywords | HCC Hepatocellular carcinoma Liver cancer Nivolumab PD-1 inhibitor |
| Issue Date | 2019 |
| Publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep |
| Citation | Journal of Hepatology, 2019, v. 71 n. 3, p. 543-552 How to Cite? |
| Persistent Identifier | http://hdl.handle.net/10722/266016 |
| ISSN | 2023 Impact Factor: 26.8 2023 SCImago Journal Rankings: 9.857 |
| ISI Accession Number ID |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Yau, TCC | - |
| dc.contributor.author | Hsu, C | - |
| dc.contributor.author | Kim, TY | - |
| dc.contributor.author | Choo, S | - |
| dc.contributor.author | Kang, YK | - |
| dc.contributor.author | Hou, MM | - |
| dc.contributor.author | Numata, K | - |
| dc.contributor.author | Yeo, W | - |
| dc.contributor.author | Chopra, A | - |
| dc.contributor.author | Ikeda, M | - |
| dc.contributor.author | Kuromatsu, R | - |
| dc.contributor.author | Moriguchi, M | - |
| dc.date.accessioned | 2018-12-17T02:16:33Z | - |
| dc.date.available | 2018-12-17T02:16:33Z | - |
| dc.date.issued | 2019 | - |
| dc.identifier.citation | Journal of Hepatology, 2019, v. 71 n. 3, p. 543-552 | - |
| dc.identifier.issn | 0168-8278 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/266016 | - |
| dc.language | eng | - |
| dc.publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep | - |
| dc.relation.ispartof | Journal of Hepatology | - |
| dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
| dc.subject | HCC | - |
| dc.subject | Hepatocellular carcinoma | - |
| dc.subject | Liver cancer | - |
| dc.subject | Nivolumab | - |
| dc.subject | PD-1 inhibitor | - |
| dc.title | Nivolumab in Advanced Hepatocellular Carcinoma: Sorafenib-Experienced Asian Cohort Analysis From the CheckMate 040 Study | - |
| dc.type | Article | - |
| dc.identifier.email | Yau, TCC: tyaucc@hku.hk | - |
| dc.identifier.authority | Yau, TCC=rp01466 | - |
| dc.description.nature | published_or_final_version | - |
| dc.identifier.doi | 10.1016/j.jhep.2019.05.014 | - |
| dc.identifier.pmid | 31668671 | - |
| dc.identifier.scopus | eid_2-s2.0-85068818799 | - |
| dc.identifier.hkuros | 296382 | - |
| dc.identifier.volume | 71 | - |
| dc.identifier.issue | 3 | - |
| dc.identifier.spage | 543 | - |
| dc.identifier.epage | 552 | - |
| dc.identifier.isi | WOS:000496939900041 | - |
| dc.publisher.place | Netherlands | - |
| dc.identifier.issnl | 0168-8278 | - |